Pieris Pharmaceuticals logo

Pieris Pharmaceuticals


Pieris Pharmaceuticals (NASDAQ: PIRS) is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way.


Add photos to showcase Pieris Pharmaceuticals’s culture


Add Pieris Pharmaceuticals’s values

Insider experiences

Share your experience of working at Pieris Pharmaceuticals

Gordon Otto
Head of Clinical Development Oncology
No reports!

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure